文献速递焦虑、强迫与应激相关障碍睡眠障碍儿童青少年精神

孕期早期使用苯二氮䓬类或Z类药物与不良新生儿结局的关联

Association between maternal benzodiazepine or Z-hypnotic use in early pregnancy and the risk of stillbirth, preterm birth, and small for gestational age: a nationwide, population-based cohort study in Taiwan.
PubMed 文献 · Lancet Psychiatry · 2023-01-01

台湾全国性队列研究纳入2 882 292例单胎妊娠,发现孕早期使用苯二氮䓬类或Z类药物与死产、早产和小于胎龄儿的粗关联在控制适应症混杂后减弱,同胞对照分析中死产和早产风险无显著增加,但小小于胎龄儿风险仍显著。

要点

  • 控制适应症混杂后,死产关联不显著,但早产和小小于胎龄儿关联仍存在。
  • 同胞对照分析中,死产和早产风险无显著增加,小小于胎龄儿风险仍显著。

核心结论

  • 孕早期使用苯二氮䓬类或Z类药物在控制未测量混杂后未显著增加死产和早产风险。
  • 临床应关注小小于胎龄儿风险增加,孕晚期处方需谨慎。

研究设计与样本

  • 台湾全国性人口基础队列研究,使用出生证明、医保和母婴健康数据库。
  • 暴露定义为孕早期(前20周)至少一次苯二氮䓬类或Z类药物处方。
  • 采用倾向评分精细分层加权逻辑回归,并进行适应症混杂控制、同胞对照和父系阴性对照分析。

主要发现

  • 控制适应症混杂后,死产关联不显著,早产和小小于胎龄儿关联仍存在。
  • 同胞对照分析中,死产和早产风险无显著增加,小小于胎龄儿风险仍显著。
  • 孕晚期暴露与死产和早产风险显著增加相关。

临床怎么用

  • 孕早期处方苯二氮䓬类或Z类药物时,应权衡小小于胎龄儿风险。
  • 孕晚期应谨慎使用这些药物,因与死产和早产风险增加相关。

局限性

  • 缺乏种族信息。
  • 观察性研究可能存在未测量混杂,尽管采用了多种控制方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Benzodiazepines and Z-hypnotics are commonly prescribed for anxiety and insomnia during pregnancy, but the evidence regarding potential adverse neonatal outcomes is insufficient because of poor control for confounding factors in previous studies. We therefore aimed to evaluate the association between the use of benzodiazepines or Z-hypnotics during early pregnancy and adverse neonatal outcomes (stillbirth, preterm birth, and small for gestational age). METHODS: We did a nationwide, population-based cohort study in Taiwan using three data sources: Taiwan's National Birth Certificate Application database, the National Health Insurance database, and the Maternal and Child Health Database. The study cohort included all singleton pregnancies of females aged 15-50 years who gave birth between Jan 1, 2004, and Dec 31, 2018. Pregnancies without valid information were excluded. Benzodiazepine and Z-hypnotic use was defined as at least one benzodiazepine or Z-hypnotic prescription during early pregnancy (the first 20 weeks of pregnancy). The primary outcomes were stillbirth (fetal death at or after 20 weeks' gestation), preterm birth (<37 weeks' gestation), and small for gestational age (birthweight below the 10th percentile for gestational age by sex). Logistic regression models with propensity score fine stratification weighting were used to control for potential confounders and examine the association between benzodiazepines or Z-hypnotics use during early pregnancy and the risk of adverse neonatal outcomes. Odds ratios (ORs) and 95% CIs were reported. We used confounding by indication control analyses, a sibling control study, and a paternal negative control design to account for unmeasured confounders. The risk associated with exposure during late pregnancy was also assessed. FINDINGS: Between Oct 7, 2021, and June 10, 2022, we analysed the study data. The cohort included 2 882 292 singleton pregnancies; of which, 75 655 (2·6%) of the mothers were dispensed one or more benzodiazepines or Z-hypnotics during early pregnancy. Women exposed during pregnancy were older (mean age at delivery was 31·0 years [SD 5·3] for exposed women vs 30·6 years [4·9] for unexposed women), had a higher prevalence of psychiatric disorders, and were more likely to have unhealthy lifestyle behaviours than unexposed women. Information about ethnicity was not available. Early pregnancy exposure was associated with adverse neonatal outcomes compared with non-exposure. The propensity score-weighted OR was 1·19 (95% CI 1·10-1·28) for stillbirth, 1·19 (1·16-1·23) for preterm birth, and 1·16 (1·13-1·19) for small for gestational age. After controlling for confounding by indication, there was no significant association between drug exposure and stillbirth risk; however, this attenuation was not observed for preterm birth and small for gestational age. In models with sibling controls that accounted for familial confounding and genetic factors, early exposure to benzodiazepines or Z-hypnotics was not associated with an increased risk of stillbirth and preterm birth, but it remained significantly associated with small for gestational age. The paternal negative control analyses with point estimates close to the null indicated no strong evidence of unmeasured confounding shared by the mother and the father. Substantially increased risks of stillbirth and preterm birth were observed for late pregnancy exposure. INTERPRETATION: Benzodiazepine or Z-hypnotic use in early pregnancy is not associated with a substantial increase in the risk of stillbirth and preterm birth after accounting for unmeasured confounding factors. Clinicians should be aware of the increased risk of small for gestational age and caution should be taken when prescribing these medications during late pregnancy. FUNDING: National Science and Technology Council, Taiwan. TRANSLATION: For the Taiwanese translation of the abstract see Supplementary Materials section.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Meng LC, Lin CW, Lin YC, et al. Association between maternal benzodiazepine or Z-hypnotic use in early pregnancy and the risk of stillbirth, preterm birth, and small for gestational age: a nationwide, population-based cohort study in Taiwan. Lancet Psychiatry. 2023. PMID: 37353262. doi:10.1016/S2215-0366(23)00148-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。